PARP and PARG Inhibitors-New Therapeutic Targets in Cancer Treatment

被引：42

作者：

Fauzee, Nilufer Jasmine Selimah ^{[1
]}

Pan, Juan ^{[1
]}

Wang, Ya-lan ^{[1
]}

机构：

[1] Chongqing Med Univ, Dept Pathol, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China

来源：

PATHOLOGY & ONCOLOGY RESEARCH | 2010年 / 16卷 / 04期

关键词：

PARP; PARG; PARP inhibitors; PARG inhibitors; ADP-RIBOSE POLYMERASE; POLY(ADP-RIBOSE) POLYMERASE; CELL-DEATH; DNA-DAMAGE; GLYCOHYDROLASE INHIBITOR; HOMOLOGOUS RECOMBINATION; BREAST-CANCER; TUMOR-GROWTH; SENSITIVITY; REPAIR;

D O I：

10.1007/s12253-010-9266-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Today, the number of cancer patients throughout the world is increasing alarmingly and as per the World Health Organisation (WHO) data and statistics the prediction for the year 2020 will be 15 million new cases as compared to only 10 million cases in year 2000 leaving us dumbfounded. A lot of effort has been put in by researchers and scientists over decades to find drugs helpful in the treatment of cancers for the benefit of patients-The latest being the Poly ADP-ribose polymerase (PARP) and the Poly ADP-ribose glycohydrolase (PARG) inhibitors. This review highlights their mechanism of action under the rationale of their use and current development in the field of cancer.

引用

页码：469 / 478

页数：10

共 107 条

[1] Caspase-3-mediated processing of poly(ADP-ribose) glycohydrolase during apoptosis [J].

Affar, EB ;

Germain, M ;

Winstall, E ;

Vodenicharov, M ;

Shah, RG ;

Salvesen, GS ;

Poirier, GG .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (04) :2935-2942

[2] Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models [J].

Albert, Jeffrey M. ;

Cao, Carolyn ;

Kim, Kwang Woon ;

Willey, Christopher D. ;

Geng, Ling ;

Xiao, Dakai ;

Wang, Hong ;

Sandler, Alan ;

Johnson, David H. ;

Colevas, Alexander D. ;

Low, Jennifer ;

Rothenberg, Mace L. ;

Lu, Bo .

CLINICAL CANCER RESEARCH, 2007, 13 (10) :3033-3042

[3] A key role for poly(ADP-Ribose) polymerase-1 activity during human dendritic cell maturation [J].

Aldinucci, Alessandra ;

Gerlini, Gianni ;

Fossati, Silvia ;

Cipriani, Giulia ;

Ballerini, Clara ;

Biagioli, Tiziana ;

Pimpinelli, Nicola ;

Borgognoni, Lorenzo ;

Massacesi, Luca ;

Moroni, Flavio ;

Chiarugi, Alberto .

JOURNAL OF IMMUNOLOGY, 2007, 179 (01) :305-312

[4] A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair [J].

Ashworth, Alan .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3785-3790

[5]

BANASIK M, 1992, J BIOL CHEM, V267, P1569

[6] SYNTHESIS OF DNA AND POLY(ADENOSINE DIPHOSPHATE RIBOSE) IN NORMAL AND CHRONIC LYMPHOCYTIC-LEUKEMIA LYMPHOCYTES [J].

BERGER, NA ;

ADAMS, JW ;

SIKORSKI, GW ;

PETZOLD, SJ ;

SHEARER, WT .

JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (01) :111-118

[7]

BHASKARA, 2009, NEUROLOGY INDIA, V57

[8]

Bhatia M, 1996, CELL GROWTH DIFFER, V7, P91

[9] MODULATION OF POLY(ADP-RIBOSE) POLYMERASE DURING NEUTROPHILIC AND MONOCYTIC DIFFERENTIATION OF PROMYELOCYTIC (NB4) AND MYELOCYTIC (HL-60) LEUKEMIA-CELLS [J].

BHATIA, M ;

KIRKLAND, JB ;

MECKLINGGILL, KA .

BIOCHEMICAL JOURNAL, 1995, 308 :131-137

[10] Poly(ADP-ribose) glycohydrolase silencing protects against H2O2-induced cell death [J].

Blenn, Christian ;

Althaus, Felix R. ;

Malanga, Maria .

BIOCHEMICAL JOURNAL, 2006, 396 :419-429

← 1 2 3 4 5 6 7 8 9 10 →